These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Lucchinetti CF; Kimmel DW; Lennon VA Neurology; 1998 Mar; 50(3):652-7. PubMed ID: 9521251 [TBL] [Abstract][Full Text] [Related]
5. Anti-Ri paraneoplastic neurological syndrome presenting with bilateral cranial nerve VI palsy and jaw dystonia-a distinctive syndrome within the anti-Ri spectrum? : Case report and literature review. Freydl E; Tinchon A; Blauensteiner K; Oberndorfer S Wien Med Wochenschr; 2024 Feb; 174(1-2):16-21. PubMed ID: 36867318 [TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic neurological autoimmunity associated with ANNA-1 autoantibody and thymoma. Vernino S; Eggenberger ER; Rogers LR; Lennon VA Neurology; 2002 Sep; 59(6):929-32. PubMed ID: 12297583 [TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic anti-Purkinje and type I anti-neuronal nuclear autoantibodies bind selectively to central, peripheral, and autonomic nervous system cells. Altermatt HJ; Rodriguez M; Scheithauer BW; Lennon VA Lab Invest; 1991 Oct; 65(4):412-20. PubMed ID: 1921331 [TBL] [Abstract][Full Text] [Related]
12. Amphiphysin autoimmunity: paraneoplastic accompaniments. Pittock SJ; Lucchinetti CF; Parisi JE; Benarroch EE; Mokri B; Stephan CL; Kim KK; Kilimann MW; Lennon VA Ann Neurol; 2005 Jul; 58(1):96-107. PubMed ID: 15984030 [TBL] [Abstract][Full Text] [Related]
13. 'Jaw clenching' in anti-Ri--antibody-associated paraneoplastic syndrome. Bekircan-Kurt CE; Temucin Ç; Elibol B; Saka E Parkinsonism Relat Disord; 2013 Jan; 19(1):132-3. PubMed ID: 22704901 [No Abstract] [Full Text] [Related]
14. Purkinje cell cytoplasmic autoantibody type 1 accompaniments: the cerebellum and beyond. McKeon A; Tracy JA; Pittock SJ; Parisi JE; Klein CJ; Lennon VA Arch Neurol; 2011 Oct; 68(10):1282-9. PubMed ID: 21670387 [TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics. Lee HR; Lennon VA; Camilleri M; Prather CM Am J Gastroenterol; 2001 Feb; 96(2):373-9. PubMed ID: 11232678 [TBL] [Abstract][Full Text] [Related]
16. Use of an oral sensory feedback device in the management of jaw-opening dystonia. Verma SP; Sinha UK Otolaryngol Head Neck Surg; 2009 Jul; 141(1):142-3. PubMed ID: 19559975 [No Abstract] [Full Text] [Related]
17. An antineuronal autoantibody in paraneoplastic opsoclonus. Budde-Steffen C; Anderson NE; Rosenblum MK; Graus F; Ford D; Synek BJ; Wray SH; Posner JB Ann Neurol; 1988 May; 23(5):528-31. PubMed ID: 3389761 [TBL] [Abstract][Full Text] [Related]
18. Deep brain stimulation for primary generalized dystonia: long-term outcomes. Isaias IU; Alterman RL; Tagliati M Arch Neurol; 2009 Apr; 66(4):465-70. PubMed ID: 19364931 [TBL] [Abstract][Full Text] [Related]
20. Paraneoplastic coma and acquired central alveolar hypoventilation as a manifestation of brainstem encephalitis in a patient with ANNA-1 antibody and small-cell lung cancer. Lee KS; Higgins MJ; Patel BM; Larson JS; Rady MY Neurocrit Care; 2006; 4(2):137-9. PubMed ID: 16627902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]